This study demonstrated a higher expression of RAMP1 for tumor-infiltrating immune cells (CD4+ T cells, cytotoxic CD8+ T cells, and NK cells) in OSCC patients compared to immune cells from the normal tissue of healthy individuals [109]. This evidence concerns the gene RAMP1 and neoplasm.